Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
Date
2017Language
en
Sujet
Résumé
Several data indicate that migraine, especially migraine with aura, is associated with an increased risk of ischemic stroke and other vascular events. Of concern is whether the risk of ischemic stroke in migraineurs is magnified by the use of hormonal contraceptives. As migraine prevalence is high in women of reproductive age, it is common to face the issue of migraine and hormonal contraceptive use in clinical practice. In this document, we systematically reviewed data about the association between migraine, ischemic stroke and hormonal contraceptive use. Thereafter a consensus procedure among international experts was done to develop statements to support clinical decision making, in terms of cardiovascular safety, for prescription of hormonal contraceptives to women with migraine. Overall, quality of current evidence regarding the risk of ischemic stroke in migraineurs associated with the use of hormonal contraceptives is low. Available data suggest that combined hormonal contraceptive may further increase the risk of ischemic stroke in those who have migraine, specifically migraine with aura. Thus, our current statements privilege safety and provide several suggestions to try to avoid possible risks. As the quality of available data is poor further research is needed on this topic to increase safe use of hormonal contraceptives in women with migraine. © 2017, The Author(s).
Collections
Related items
Showing items related by title, author, creator and subject.
-
Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: A consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)
Sacco S., Merki-Feld G.S., Ægidius K.L., Bitzer J., Canonico M., Gantenbein A.R., Kurth T., Lampl C., Lidegaard Ø., Anne Macgregor E., Maassenvandenbrink A., Mitsikostas D.-D., Nappi R.E., Ntaios G., Paemeleire K., Sandset P.M., Terwindt G.M., Vetvik K.G., Martelletti P. (2018)We systematically reviewed data about the effect of exogenous estrogens and progestogens on the course of migraine during reproductive age. Thereafter a consensus procedure among international experts was undertaken to ... -
Serum Homocysteine, Pyridoxine, Folate, and Vitamin B12 Levels in Migraine: Systematic Review and Meta-Analysis
Liampas I., Siokas V., Mentis A.-F.A., Aloizou A.-M., Dastamani M., Tsouris Z., Aslanidou P., Brotis A., Dardiotis E. (2020)Background: Migraine, especially migraine with aura (MA), has been linked to increased risk for ischemic cerebrovascular disease. The possible role of elevated serum homocysteine (Hcy, a cause of thrombophilia) in migraine ... -
Serum lipid abnormalities in migraine: A meta-analysis of observational studies
Liampas I., Mylonas K.S., Brotis A., Dervenis P., Siokas V., Mentis A.-F.A., Dastamani M., Aloizou A.-M., Tsouris Z., Aslanidou P., Bakoyiannis C., Dardiotis E. (2021)Background: The association of migraine with vascular comorbidities is long-established. The contribution of the “traditional” cardiovascular risk factors to this connection remains unclear. Objective: To determine-quantify ...